4ZG.F 2.37 (-6.32%)
FR0011049824Medical Diagnostics & ResearchDiagnostics & Research

Median Technologies (4ZG.F) Competitor Comparison

We are evaluating the key criteria listed to compare Median Technologies (4ZG.F) against its competitors in the Diagnostics & Research industry.

Performance 3 years - 4ZG.F ranking 0 / 58

These are the competitors of Median Technologies in the industry Diagnostics & Research ranked by performance 3 years
1. Natera NTRA
271.13
2. Meridian Bioscience VIVO
246.63
3. RadNet RDNT
141.18
4. Medpace Holdings MEDP
88.2
5. Lantheus Holdings LNTH
69.83
6. Sera Prognostics SERA
45.92
7. Heska HSKA
41.31
8. PerkinElmer PKI
21.19
9. Quest Diagnostics DGX
20.73
10. Ortho Clinical Diagnostics Holdings OCDX
13.74
11. Waters WAT
9.25
12. Anixa Biosciences ANIX
4.62
13. Laboratory Corp of America Holdings LH
-5.97
14. Qiagen QGEN
-12.92
15. Twist Bioscience TWST
-13.43
16. IDEXX Laboratories IDXX
-16.5
17. Agilent Technologies A
-18.95
18. Syneos Health SYNH
-19.01
19. NeoGenomics NEO
-22.04
20. Olink Holding OLK
-22.2
21. Mettler-Toledo MTD
-23.25
22. Danaher DHR
-23.36
23. Thermo Fisher Scientific TMO
-24.86
24. Exagen XGN
-27.81
25. Guardant Health GH
-37.54
26. Bioventus BVS
-38.86
27. IQVIA Holdings IQV
-39.74
28. Exact Sciences EXAS
-40.11
29. Icon ICLR
-43.09
30. DexCom DXCM
-44.01
31. CareDx CDNA
-49.21
32. Sotera Health SHC
-51.64
33. Personalis PSNL
-53.16
34. MaxCyte MXCT
-53.31
35. Charles River Laboratories CRL
-62.63
36. Psychemedics PMD
-63.68
37. Global Cord Blood CO
-67.25
38. Myriad Genetics MYGN
-67.98
39. Fulgent Genetics FLGT
-68.07
40. Enzo Biochem ENZ
-70.36
41. Biodesix BDSX
-72.97
42. National Research NRC
-73.09
43. Precipio PRPO
-75.29
44. Illumina ILMN
-78.22
45. MDxHealth MDXH
-80.02
46. Pacific Biosciences of California PACB
-84.46
47. Neogen NEOG
-85.37
48. bioAffinity Technologies BIAF
-88.45
49. Co-Diagnostics CODX
-88.94
50. Trinity Biotech TRIB
-89.06
51. Organovo Holdings ONVO
-89.19
52. Interpace Biosciences IDXG
-89.51
53. Neuronetics STIM
-91.07
54. Inotiv NOTV
-93.49
55. DarioHealth DRIO
-93.77
56. SeqLL SQL
-95.69
57. Prenetics Global PRE
-96.53
58. Aspira Womens Health AWH
-98.83

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.